Fig. 2From: Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathwaysThe results of network pharmacology. A The overlapping targets of Syringin and BC. B A PPI network of overlapping targets. C The top 25 of GO enrichment entries. D The top 25 of KEGG pathways. E A “C-T-P” networkBack to article page